All Companies

LLY

Eli Lilly & Co.

Pharmaceutical Preparations

$1,152.93updated Sep 19, 2026

Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Michael A. RulliRAug 7, 2026Jul 1, 2026Sell$1,001 - $15,000-3.26%
Michael A. RulliRAug 7, 2026Jan 2, 2026Buy$1,001 - $15,000+6.72%
Michael A. RulliRAug 7, 2026Dec 2, 2025Sell$1,001 - $15,000+10.21%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+31.28%
Dan NewhouseRJul 17, 2026Jul 10, 2026Sell$1,001 - $15,000-3.00%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.23%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.23%
David TaylorRMar 6, 2026Feb 26, 2026Buy$1,001 - $15,000+12.81%
David TaylorRFeb 20, 2026Feb 9, 2026Sell$1,001 - $15,000+10.36%
David TaylorRFeb 2, 2026Jan 16, 2026Sell$1,001 - $15,000+11.03%
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+6.88%
David TaylorRDec 19, 2025Dec 10, 2025Sell$1,001 - $15,000+16.03%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+8.80%
Shelley Moore CapitoRNov 4, 2025Oct 24, 2025Buy$1,001 - $15,000+39.67%
John BoozmanRSep 12, 2025Aug 22, 2025Buy$1,001 - $15,000+62.00%
John BoozmanRSep 12, 2025Aug 11, 2025Buy$1,001 - $15,000+81.50%
David TaylorRSep 2, 2025Aug 14, 2025Buy$15,001 - $50,000+68.45%
David TaylorRSep 2, 2025Aug 14, 2025Buy$1,001 - $15,000+68.45%
Lisa C. McClainRAug 13, 2025Jul 16, 2025Sell$1,001 - $15,000+45.98%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Buy$1,001 - $15,000+45.82%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Sell$1,001 - $15,000+49.01%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$100,001 - $250,000+52.59%
Marjorie Taylor GreeneRMay 19, 2025May 14, 2025Buy$1,001 - $15,000+61.12%
Dan NewhouseRMay 16, 2025Apr 11, 2025Sell$1,001 - $15,000+57.42%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+52.27%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+40.94%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+40.35%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+58.75%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+24.01%
Ashley MoodyRMar 22, 2025Mar 6, 2025Buy$100,001 - $250,000+26.31%
Marjorie Taylor GreeneRJan 27, 2025Jan 21, 2025Buy$1,001 - $15,000+55.31%